INTRODUCTION
During systemic inflammatory response syndrome (SIRS), severe sepsis, or septic shock, the redistribution of blood volume and pulmonary edema may increase arterial lactatemiathe and cytokines, which later lead to multiple organ dysfunction syndrome (MODS) . [1] Early goal-directed therapy (EGDT) and fl uid resuscitation at the early stage can't prevent such development. [2] Clinically, refractory shock and irreversible shock refer to types of shock that present particularly difficult problems. The term refractory shock is applied when, in spite of apparently adequate therapy, the shock state continues. The shock which could not be rectified and sustained deterioration was named as refractory septic shock. Wang et al [3, 4] reported that high-volume hemofi ltration (HVHF) as a method of continuous blood purification (CBP) is technically possible in severe acute pancreatitis (SAP) patients complicated with MODS. Continuous HVHF is expected to become a benefi cial adjunct therapy for SAP patients complicated with MODS.
This study was undertaken to explore the effects of fluid resuscitation and HVHF on alveolar-arterial oxygen exchange, Acute Physiology and Chronic Health Evaluation II (APACHE II) score in patients with refractory septic shock.
METHODS

Patients
A total of 89 patients with refractory septic shock, who had been admitted to ICU of the Provincial Hospital Affiliated to Shandong University from August 2006 and December 2009, were enrolled in this retrospective study. Gastric carcinoma was found in 8 of the 89 patients, colon cancer in 18, lung cancer in 10, esophageal carcinoma in 3, thymoma in 1, liver cancer in 6, cancer of the pancreas in 2, history of neurosurgery in 9, rib fracture in 12, plenic rupture in 1, acute pregnancy fat liver in 6, postpartum hemorrhage in 1, peripartal cardiomyopathy in 2, severe acute pancreatitis in 6, and severe pneumonia in 4.
The 89 patients were randomly divided into two groups: fluid resuscitation (group A, n=41), and fluid resuscitation plus high-volume hemofi ltration (group B, n=48). In group A, there were 23 males and 18 females, with age ranging from 22 to 74 (55.7±18.5) years, and APACHE II score was 28.3±9.3. In group B, there were 26 males and 22 females, with age ranging from 25 to 78 (57.2±16.4) years, and APACHE II score was 27.5±8.9. There were no signifi cant differences in age, gender, and disease severity between the two groups.
In group A, patients were treated with fluid resuscitation, drugs for vessel activity enhancement, anti-bacterial medication, and mechanical ventilation. The patients with refractory septic shock received six hours of early goal-directed therapy (EGDT), and the goal of the treatment was set for the following: preload (central venous pressure 8-12 mmHg), afterload (65 mmHg<mean arterial pressure<90 mmHg), cardiac contractility (mixed venous oxygen saturation>70%), and urinary volume>0.5 mL/kg per hour. [5] In group B, except for fl uid resuscitation, the patients continued to receive high-volume hemofiltration (HV-CVVH) for at least 72 hours. Indwelling catheters (Prismafl ex corporation, Switzerland) in the femoral vein were adopted for vascular access in these patients. The HVHF model was made with pre-displacement 70%-80% and filter replacement per 24 hours. Heparin was used for anti-coagulation at an initial dose of 15-25 U/kg. The displacement fl uid velocity was 2000-3000 mL/h (50-70 mL/kg per hour ), displacement volume was more than 60 L/d, and blood fl ow velocity was 150-200 mL/min.
Parameters of hemodynamics
T h e c e n t r a l v e n o u s o x y g e n c o n t e n t ( C c v O 2 ) and arterial oxygen content (C a O 2 ) were detected through subclavian vein pincture and arteriopuncture, respectively. The oxygen extraction rate (O 2 ER) was calculated with the following equation:
Indexes of oxygen exchange
The 0.5 mL blood was collected from the radial artery, and was anticoagulated with heparin. GEM Premier 3000 (GEM Premier Company, Germany) was used for the arterial blood gas analysis. The indexes of oxygen exchange included:1) alveolararterial oxygen pressure difference: 
Outcome measures
In-hospital mortality (primary efficacy outcome), end points with respect to hemodynamic parameters, oxygen exchange parameters, and Acute Physiology and Chronic Health Evaluation II (APACHE II) scores were obtained serially for 7 days and compared between the study groups. [6] Statistical analysis Data were expressed as mean ± standard deviation and the analysis of variance was performed with SPSS 12.0 software. The average value of the two groups was determined with Student's t test and the chi-square t test. A P value less than 0.05 or 0.01 was considered statistically signifi cant.
RESULTS
Hemodynamics and oxygen exchange
The values of C cv O 2 , C a O 2 , O 2 ER were compared between the two groups ( Table 1) . The values of P (A-a) DO 2 , P a O 2 /P A O 2 , respiratory index (RI) and oxygenation index (OI) between the two groups are listed in Table 2 .
APACHE II scores after HVHF
In group A, 11 patients died, with a mortality of 26.8% and in group B, 5 patients died, with a mortality of 10.4%. There was a signifi cant difference in mortality between the two groups (P<0.05). The APACHE II score in group B was lower than that in group A (Table 3) .
DISCUSSION
Infective or noninfective injury stimulates the immune system to produce infl ammatory cytokines, such as TNF-α, IL-1, IL-6, IL-10, prostaglandin, leukotriene, platelet activating factor, and nitric oxide, which may cause the damage of vascular endothelial cell function in the lung, increase the capillary permeability, and fi nally result in pulmonary edema and oxygenation dysfunction. Sepsis is a potentially deadly medical condition that is characterized by a whole-body inflammatory state (called a systemic inflammatory response syndrome or SIRS) and the presence of a known or suspected infection. [7, 8] The body may develop this inflammatory response by the immune system to microbes in blood, urine, lungs, skin, or other tissues, and then MODS may develop. Severe sepsis is accompanied by single or multiple organ dysfunction or failure, eventually leading to death. [9] Although our understanding of the complex pathophysiological alterations that occur in severe sepsis and septic shock has increased greatly as a result of recent clinical and preclinical studies, mortality associated with the disorder remains unacceptably high, ranging from 30% to 50%. [10] [11] [12] [13] The rapid diagnosis and effective management of sepsis is critical to successful treatment. [14] The Surviving Sepsis Campaign, an initiative of the European Society of Intensive Care Medicine (ESICM), the International Sepsis Forum (ISF), and the Society of Critical Care Medicine, was developed to improve the management, diagnosis, and treatment of sepsis. The agreement among the three societies and funding for the campaign came to a conclusion on December 31, 2008. [15] HVHF refers to displacement liquid velocity>45 mL/ kg per hour or ultrafi ltration volume>60 L/d. [16] Compared with CVVHF, HVHF can clear not only solutes with small molecular weight (water, serum creatinine, urea World J Emerg Med, Vol 2, No 2, 2011 Ren et al nitrogen, and electrolysis), but also solutes with large molecular weight (inflammatory factors, and toxic substance), which may interrupt waterfall-like chain reaction of inflammatory factors, and alleviate organ injury. HVHF can increase P a O 2 and oxygenation index, decrease P a CO 2 , improve heart and lung function, remove toxin, and ameliorate blood electrolyte disturbances and acid-base imbalance. HVHF therapy was safe and effective for MODS. [17, 18] ARDS often occurs after major operation, especially thoracic operation or abdominal operation. The manifestations of ARDS mainly present as respiratory distress and hypoxemia, and the mechanism may be connected with the increased capillary permeability and pulmonary edema after SIRS induced by trauma. Though C cv O 2 , C a O 2 , and P a O 2 can be easily detected, they are easy to be affected by F i O 2 . The respiratory index (RI) and oxygenation index (OI) are parameters of mechanical ventilation, and OI can truly reflect the degree of lung injury. Because P a O 2 doesn't change obviously during the early stage of ARDS, OI can't timely refl ect the lung injury during ARDS. P (A-a) DO 2 can reflect pulmonary shunt, ventilation/perfusion ratio imbalance, but it is affected by F i O 2 . RI is the ratio of P A-a O 2 and P a O 2 , and without the effect of F i O 2 , it can reflect pulmonary gas exchange and oxygenation changes earlier than P (A-a) DO 2 . P (A-a) DO 2 , P a O 2 /P A O 2 , RI and OI should be considered for the assessing lung oxygenation during early phase. In this study, we found P (A-a) DO 2 , P a O 2 /P A O 2 , RI and OI were improved after HVHF. This indicated that the combination of fluid resuscitation and HVHF could effectively improve pulmonary edema and pulmonary oxygenation.
HVHF has beneficial effects on severe sepsis, improving hemodynamics and unselectively removing proinflammatory and anti-inflammatory mediators. [19] [20] [21] [22] [23] Animal experiments showed that early HVHF can remove excess infl ammatory mediators in the circulation, stabilize neutrophils, improve immune function, and prevent MODS. In this study, the mortality was significantly higher in group A than in group B (26.8% vs.10.4%, P<0.05) at the 7th day between the two groups, and the APACHE II score at the 7th day was also signifi cantly higher in group A than in group B (17.2±6.8 vs. 8.2±3.8, P<0.01).
In summary, compared with fluid resuscitation, HVHF combined with fluid resuscitation can improve alveolar-arterial-oxygen exchange, decrease the APACHE II score in patients with refractory septic shock, and thus increase the survival rate of these patients.
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